SALE
市場調査レポート

米国の体外診断薬市場:2011年(免疫化学、分子診断、献血者スクリーニング、止血、血液学検査、ポイントオブケア試験)

U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)

発行 iData Research Inc. 商品コード 210250
出版日 ページ情報 英文 322 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
10% OFF 2016年07月31日まで 期間限定キャンペーン

ご注意: Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の体外診断薬市場:2011年(免疫化学、分子診断、献血者スクリーニング、止血、血液学検査、ポイントオブケア試験) U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)
出版日: 2011年09月01日 ページ情報: 英文 322 Pages
概要

2017年までに、米国の体外診断薬市場は100億米ドルに近づくと予測されています。2010年、同市場ではFDAが承認した新たなアッセイの導入により大きく成長しました。そして多くの技術が確立され設備市場は飽和状態となりました。しかし、新規アッセイの検査と開発のためのさらなる技術革新や需要が同市場の成長を促進するものとみられています。

当レポートでは、米国の体外診断薬市場について包括的に分析し、市場全体の動向とともに、免疫化学、分子診断、献血者スクリーニング、止血、血液学検査、ポイントオブケア試験のセグメント別動向と予測、競合動向をまとめ、概略以下の構成でお届けします。

目次

図表

第1章 エグゼクティブサマリー

第2章 調査方法

第3章 米国の体外診断薬市場

  • イントロダクション
  • 市場概要
  • セグメント別動向分析
  • 市場促進因子と阻害因子
  • 競合分析
  • 合併・買収

第4章 免疫化学市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 免疫化学分析装置
    • 免疫測定
    • 臨床化学
    • 自動尿分析装置
  • 市場促進因子と阻害因子
  • 競合分析

第5章 分子診断市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 分子診断装置
    • 分子診断アッセイ
  • 市場促進因子と阻害因子
  • 競合分析

第6章 献血者スクリーニング市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 献血者スクリーニング分析装置
    • 献血者スクリーニングアッセイ
  • 市場促進因子と阻害因子
  • 競合分析

第7章 止血市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 止血分析装置
    • 止血試薬
  • 市場促進因子と阻害因子
  • 競合分析

第8章 血液学検査市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 血液学分析装置
    • 血液学試薬
  • 市場促進因子と阻害因子
  • 競合分析

第9章 ポイントオブケア試験市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
    • 臨床化学
    • 血液ガス検査
    • ポイントオブケア尿検査
    • ポイントオブケア血糖検査
  • 市場促進因子と阻害因子
  • 競合分析

略語

図表

目次
Product Code: iDATA_USIVD11_RPT

By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion.

The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include:

  • Immunochemistry,
    • Immunochemistry Analyzer
    • Immunology Diagnostic
    • Chemistry Diagnostics
    • Automated Urinalysis Instrument
  • Molecular Diagnostics
    • Molecular Diagnostics Reagent
    • Molecular Diagnostics Instrument
  • Hemostasis
    • Hemostasis Analyzer
    • Hemostasis Reagent
  • Hematology
    • Hematology Analyzer Market
    • Hematology Reagent
  • Blood Donor Screening
    • Blood Screening Analyzer
    • Blood Screening Assay Kit
  • Point-of-Care Testing
    • Blood Gas Testing
    • Urinalysis Testing
    • Blood Glucose Testing

In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food and Drug Administration (FDA) approved assays. That year, many technologies were well established and equipment markets were saturated. However, innovation, demand for testing and development of new assays will drive market growth.

Within the in vitro diagnostics market, companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

1. EXECUTIVE SUMMARY

  • 1.1. U.S.MARKET FOR IN VITRO DIAGNOSTICS
  • 1.2. GROWTH TRENDS BY SEGMENT
  • 1.3. IMMUNOCHEMISTRY MARKET
  • 1.4. MOLECULAR DIAGNOSTICS MARKET
  • 1.5. BLOOD DONOR SCREENING MARKET
  • 1.6. HEMOSTASIS MARKET
  • 1.7. HEMATOLOGY MARKET
  • 1.8. POINT-OF-CARE TESTING MARKET
  • 1.9. COMPETITIVE ANALYSIS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA' S 9-STEP METHODOLOGY
    • 2.2.1. Step 1: Project Initiation & Team Selection
    • 2.2.2. Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3. Step 3: Preparation for Interviews & Questionnaire Design
    • 2.2.4. Step 4: Performing Primary Research
    • 2.2.5. Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6. Step 6: Market Forecast and Analysis
    • 2.2.7. Step 7: Identify Strategic Opportunities
    • 2.2.8. Step 8: Final Review and Market Release
    • 2.2.9. Step 9: Customer Feedback and Market Monitoring

3. U.S. MARKET FOR IN VITRO DIAGNOSTICS

  • 3.1. INTRODUCTION
  • 3.2. MARKET OVERVIEW
  • 3.3. TREND ANALYSIS BY SEGMENT
  • 3.4. MARKET DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE ANALYSIS
    • 3.5.1. Herfindahl Index
  • 3.6. MERGERS AND ACQUISITIONS

4. IMMUNOCHEMISTRY MARKET

  • 4.1. INTRODUCTION
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Immunochemistry Analyzer Market
    • 4.3.2. Immunoassay Market
      • 4.3.2.1. Immunoassay Analyzer Market
      • 4.3.2.2. Immunoassay Reagent Market
    • 4.3.3. Clinical Chemistry Market
      • 4.3.3.1. Clinical Chemistry Analyzer Market
        • 4.3.3.1.1. High-Volume Clinical Chemistry Analyzer Market
        • 4.3.3.1.2. Medium-Volume Clinical Chemistry Analyzer Market
        • 4.3.3.1.3. Low-Volume Clinical Chemistry Analyzer Market
      • 4.3.3.2. Clinical Chemistry Reagent Market
    • 4.3.4. Automated Urinalysis Analyzer Market
  • 4.4. MARKET DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS

5. MOLECULAR DIAGNOSTICS MARKET

  • 5.1. INTRODUCTION
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Molecular Diagnostics Instrument Market
    • 5.3.2. Molecular Diagnostics Assay Market
      • 5.3.2.1. Infectious Disease Assay Market
        • 5.3.2.1.1. Blood-Borne Virus Assay Market
        • 5.3.2.1.2. Women' s Health Assay Market
        • 5.3.2.1.3. MRSA and CMV Assay Market
      • 5.3.2.2. Genetic Diagnostics Assay Market
      • 5.3.2.3. Oncology Assay Market
  • 5.4. MARKET DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

6. BLOOD DONOR SCREENING MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1.1. Blood Donor Screening Analyzer Market
    • 6.3.1.2. Blood Donor Screening Assay Market
  • 6.4. MARKET DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE ANALYSIS

7. HEMOSTASIS MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1.1. Hemostasis Analyzer Market
    • 7.3.1.2. Hemostasis Reagent Market
  • 7.4. MARKET DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE ANALYSIS

8. HEMATOLOGY MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET FORECAST AND ANALYSIS
    • 8.3.1. Hematology Analyzer Market
      • 8.3.1.1. High-End Analyzer Market
      • 8.3.1.2. Low-End Analyzer Market
    • 8.3.2. Hematology Reagent Market
  • 8.4. MARKET DRIVERS AND LIMITERS
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. COMPETITIVE ANALYSIS

9. POINT-OF-CARE TESTING MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Clinical Chemistry Market
      • 9.3.1.1. Clinical Chemistry Analyzer Market
      • 9.3.1.2. Clinical Chemistry Reagent Market
    • 9.3.2. Blood Gas Testing Market
      • 9.3.2.1. Blood Gas Analyzer Market
        • 9.3.2.1.1. Handheld Blood Gas Analyzer Market
        • 9.3.2.1.2. Decentralized Blood Gas Analyzer Market
      • 9.3.2.2. Blood Gas Reagent Market
    • 9.3.3. Point-of-Care Urinalysis Market
      • 9.3.3.1. Urinalysis Analyzer Market
      • 9.3.3.2. Urinalysis Test Strip Market
    • 9.3.4. Point-of-Care Blood Glucose Testing Market
      • 9.3.4.1. POC Blood Glucose Analyzer Market
      • 9.3.4.2. POC Blood Glucose Test Strip Market
  • 9.4. MARKET DRIVERS AND LIMITERS
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

U.S. MARKET FOR IN VITRO DIAGNOSTICS

  • Figure 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 3-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 - 2017
  • Figure 3-3: Market Drivers and Limiters, In Vitro Diagnostics Market, 2010
  • Figure 3-4: Leading Competitors, In Vitro Diagnostics Market, 2010 (Part 1 of 2)
  • Figure 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010 (Part 2 of 2)
  • Figure 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010

IMMUNOCHEMISTRY MARKET

  • Figure 4-1: Total Immunochemistry Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 4-2: Total Immunochemistry Market, U.S., 2007 - 2017
  • Figure 4-3: Immunochemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 4-4: Total Immunoassay Market, U.S., 2007 - 2017
  • Figure 4-5: Immunoassay Analyzer Market, U.S., 2007 - 2017
  • Figure 4-6: Immunoassay Market Test Groups
  • Figure 4-7: Total Immunoassay Reagent Market, U.S., 2007 - 2017
  • Figure 4-8: Immunoassay Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 4-9: Immunoassay Reagent ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 4-10: Immunoassay Reagent Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 4-11: Total Clinical Chemistry Market, U.S., 2007 - 2017
  • Figure 4-12: Total Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 4-13: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 4-14: Medium-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 4-15: Low-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 4-16: Total Clinical Chemistry Reagent Market, U.S., 2007 - 2017
  • Figure 4-17: Clinical Chemistry Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 4-18: Clinical Chemistry Reagent ASP by Segment, U.S., 2007 - 2017
  • Figure 4-19: Clinical Chemistry Reagent Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 4-20: Automated Urinalysis Instrument Market, U.S., 2007 - 2017
  • Figure 4-21: Market Drivers and Limiters, Immunochemistry Market, 2010
  • Figure 4-22: Leading Competitors, Immunochemistry Market, 2010

MOLECULAR DIAGNOSTICS MARKET

  • Figure 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-2: Total Molecular Diagnostics Market, U.S., 2007 - 2017
  • Figure 5-3: Molecular Diagnostics Instrument Market, U.S., 2007 - 2017
  • Figure 5-4: Total Molecular Diagnostics Assay Market, U.S., 2007 - 2017
  • Figure 5-5: Total Infectious Disease Assay Market, U.S., 2007 - 2017
  • Figure 5-6: Total Blood-Borne Virus Assay Market, U.S., 2007 - 2017
  • Figure 5-7: Blood-Borne Virus Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 5-8: Blood-Borne Virus Assay ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 5-9: Blood-Borne Virus Assay Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-10: Total Women' s Health Assay Market, U.S., 2007 - 2017
  • Figure 5-11: Total Women' s Health Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 5-12: Total Women' s Health Assay ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 5-13: Total Women' s Health Assay Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-14: Total MRSA and CMV Assay Market, U.S., 2007 - 2017
  • Figure 5-15: Total MRSA and CMV Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 5-16: Total MRSA and CMV Assay ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 5-17: Total MRSA and CMV Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-18: Total Genetic Diagnostics Assay Market, U.S., 2007 - 2017
  • Figure 5-19: Total Genetic Diagnostics Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 5-20: Total Genetic Diagnostics Assay ASP by Segment, U.S., 2007 - 2017
  • Figure 5-21: Total Genetic Diagnostics Assay Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-22: Total Oncology Assay Market, U.S., 2007 - 2017
  • Figure 5-23: Total Oncology Tests Sold by Segment, U.S., 2007 - 2017
  • Figure 5-24: Total Oncology Assay ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 5-25: Total Oncology Assay Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 5-26: Market Drivers and Limiters, Molecular Diagnostics Market, 2010
  • Figure 5-27: Leading Competitors, Molecular Diagnostics Market, 2010

BLOOD DONOR SCREENING MARKET

  • Figure 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 6-2: Total Blood Donor Screening Market, U.S., 2007 - 2017
  • Figure 6-3: Blood Donor Screening Analyzer Market, U.S., 2007 - 2017
  • Figure 6-4: Total Blood Donor Screening Assay Market, U.S., 2007 - 2017
  • Figure 6-5: Blood Donor Screening Units Sold by Segment, U.S., 2007 - 2017
  • Figure 6-6: Blood Donor Screening Assay ASP by Segment, U.S., 2007 - 2017 (US$)
  • Figure 6-7: Blood Donor Screening Assay Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 6-8: Market Drivers and Limiters, Blood Donor Screening Market, 2010
  • Figure 6-9: Leading Competitors, Blood Donor Screening Market, 2010

HEMOSTASIS MARKET

  • Figure 7-1: Hemophilia Classification
  • Figure 7-2: Total Hemostasis Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 7-3: Total Hemostasis Market, U.S., 2007 - 2017
  • Figure 7-4: Hemostasis Analyzer Market, U.S., 2007 - 2017
  • Figure 7-5: Hemostasis Reagent Market, U.S., 2007 - 2017
  • Figure 7-6: Market Drivers and Limiters, Hemostasis Market, 2010
  • Figure 7-7: Leading Competitors, Hemostasis Market, 2010

HEMATOLOGY MARKET

  • Figure 8-1: Total Hematology Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 8-2: Total Hematology Market, U.S., 2007 - 2017
  • Figure 8-3: Total Hematology Analyzer Market, U.S., 2007 - 2017
  • Figure 8-4: High-End Analyzer Market, U.S., 2007 - 2017
  • Figure 8-5: Low-End Analyzer Market, U.S., 2007 - 2017
  • Figure 8-6: Hematology Reagent Market, U.S., 2007 - 2017
  • Figure 8-7: Market Drivers and Limiters, Hematology Market, 2010
  • Figure 8-8: Leading Competitors, Hematology Market, 2010

POINT-OF-CARE TESTING MARKET

  • Figure 9-1: Total POC Testing Market by Segment, U.S., 2007 - 2017 (US$M)
  • Figure 9-2: Total POC Testing Market Segments by Percentage, U.S., 2007 - 2017
  • Figure 9-3: Total POC Testing Market by Product Type, U.S., 2007 - 2017
  • Figure 9-4: Total POC Testing Market, U.S., 2007 - 2017
  • Figure 9-5: Clinical Chemistry Market, U.S., 2007 - 2017
  • Figure 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Figure 9-7: Clinical Chemistry Reagent Market, U.S., 2007 - 2017
  • Figure 9-8: Blood Gas Testing Market, U.S., 2007 - 2017
  • Figure 9-9: Total Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Figure 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Figure 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Figure 9-12: Total Blood Gas Reagent Market, U.S., 2007 - 2017
  • Figure 9-13: Blood Gas Reagent Units Sold by Packaging Type Market, U.S., 2007 - 2017
  • Figure 9-14: Blood Gas Reagent ASP by Packaging Type Market, U.S., 2007 - 2017 (US$)
  • Figure 9-15: Blood Gas Reagent Market by Packaging Type, U.S., 2007 - 2017 (US$M)
  • Figure 9-16: POC Urinalysis Market, U.S., 2007 - 2017
  • Figure 9-17: Urinalysis Analyzer Market, U.S., 2007 - 2017
  • Figure 9-18: POC Urinalysis Test Strip Market, U.S., 2007 - 2017
  • Figure 9-19: POC Blood Glucose Testing Market, U.S., 2007 - 2017
  • Figure 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 - 2017
  • Figure 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 - 2017
  • Figure 9-22: Market Drivers and Limiters, Point-of-Care Testing Market, 2010
  • Figure 9-23: Leading Competitors, Point-of-Care Testing Market, 2010

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING

  • Figure 11-1: Market Proportion by Testing Setting, 2010

LIST OF CHARTS

EXECUTIVE SUMMARY

  • Chart 1-1: Total U.S. In Vitro Diagnostics Market by Segment, U.S., 2010
  • Chart 1-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 - 2017
  • Chart 1-3: Immunochemistry Assay Volume Growth Rates by Segment, U.S., 2007 - 2017
  • Chart 1-4: Infectious Disease Assay Market by Segment, U.S., 2010
  • Chart 1-5: Blood Donor Screening Market, U.S., 2010
  • Chart 1-6: Hemostasis Market by Segment, U.S., 2010
  • Chart 1-7: Hematology Market by Segment, U.S., 2007 - 2017
  • Chart 1-8: POC Testing Market, U.S., 2007 - 2017
  • Chart 1-9: Leading Competitors, In Vitro Diagnostics Market, U.S., 2010

RESEARCH METHODOLOGY

U.S. MARKET FOR IN VITRO DIAGNOSTICS

  • Chart 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 - 2017
  • Chart 3-2: Total In Vitro Diagnostics Market by Segment, U.S., 2010
  • Chart 3-3: Total In Vitro Diagnostics Market by Segment, U.S., 2017
  • Chart 3-4: Growth Rates by Segment, In Vitro Diagnostics Market, U.S., 2007 - 2017
  • Chart 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010
  • Chart 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010

IMMUNOCHEMISTRY MARKET

  • Chart 4-1: Total Immunochemistry Market by Segment, U.S., 2007 - 2017
  • Chart 4-2: Total Immunochemistry Market by Segment, U.S., 2010
  • Chart 4-3: Total Immunochemistry Market by Segment, U.S., 2017
  • Chart 4-4: Total Immunochemistry Market, U.S., 2007 - 2017
  • Chart 4-5: Immunochemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 4-6: Total Immunoassay Market, U.S., 2007 - 2017
  • Chart 4-7: Immunoassay Analyzer Market, U.S., 2007 - 2017
  • Chart 4-8: Total Immunoassay Reagent Market, U.S., 2007 - 2017
  • Chart 4-9: Cardiovascular Reagent Market, U.S., 2007 - 2017
  • Chart 4-10: Cancer Reagent Market, U.S., 2007 - 2017
  • Chart 4-11: Infectious Disease Reagent Market, U.S., 2007 - 2017
  • Chart 4-12: Metabolic Reagent Market, U.S., 2007 - 2017
  • Chart 4-13: Endocrine Reagent Market, U.S., 2007 - 2017
  • Chart 4-14: Reproductive and Fertility Reagent Market, U.S., 2007 - 2017
  • Chart 4-15: Autoimmune Reagent Market, U.S., 2007 - 2017
  • Chart 4-16: Total Clinical Chemistry Market, U.S., 2007 - 2017
  • Chart 4-17: Total Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 4-18: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 4-19: Medium-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 4-20: Low-Volume Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 4-21: Total Clinical Chemistry Reagent Market, U.S., 2007 - 2017
  • Chart 4-22: General Chemistry Reagent Market, U.S., 2007 - 2017
  • Chart 4-23: Specific Protein Reagent Market, U.S., 2007 - 2017
  • Chart 4-24: Therapeutic Drug Monitoring Reagent Market, U.S., 2007 - 2017
  • Chart 4-25: Drugs of Abuse Reagent Market, U.S., 2007 - 2017
  • Chart 4-26: Special Chemistry Reagent Market, U.S., 2007 - 2017
  • Chart 4-27: Automated Urinalysis Instrument Market, U.S., 2007 - 2017
  • Chart 4-28: Leading Competitors, Immunochemistry Market, 2010

MOLECULAR DIAGNOSTICS MARKET

  • Chart 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 - 2017
  • Chart 5-2: Total Molecular Diagnostics Market by Segment, U.S., 2010
  • Chart 5-3: Total Molecular Diagnostics Market by Segment, U.S., 2017
  • Chart 5-4: Total Molecular Diagnostics Market, U.S., 2007 - 2017
  • Chart 5-5: Molecular Diagnostics Instrument Market, U.S., 2007 - 2017
  • Chart 5-6: Total Molecular Diagnostics Assay Market, U.S., 2007 - 2017
  • Chart 5-7: Total Infectious Disease Assay Market, U.S., 2007 - 2017
  • Chart 5-8: Total Blood-Borne Virus Assay Market, U.S., 2007 - 2017
  • Chart 5-9: HIV Assay Market, U.S., 2007 - 2017
  • Chart 5-10: HCV Assay Market, U.S., 2007 - 2017
  • Chart 5-11: HBV Assay Market, U.S., 2007 - 2017
  • Chart 5-12: Total Women' s Health Assay Market, U.S., 2007 - 2017
  • Chart 5-13: HPV Assay Market, U.S., 2007 - 2017
  • Chart 5-14: HSV Assay Market, U.S., 2007 - 2017
  • Chart 5-15: CT/GC Assay Market, U.S., 2007 - 2017
  • Chart 5-16: Total MRSA and CMV Assay Market, U.S., 2007 - 2017
  • Chart 5-17: MRSA Assay Market, U.S., 2007 - 2017
  • Chart 5-18: CMV Assay Market, U.S., 2007 - 2017
  • Chart 5-19: Total Genetic Diagnostics Assay Market, U.S., 2007 - 2017
  • Chart 5-20: CF Assay Market, U.S., 2007 - 2017
  • Chart 5-21: Inherited Thrombophilia Assay Market, U.S., 2007 - 2017
  • Chart 5-22: Total Oncology Assay Market, U.S., 2007 - 2017
  • Chart 5-23: Breast Cancer Assay Market, U.S., 2007 - 2017
  • Chart 5-24: Colorectal Cancer Assay Market, U.S., 2007 - 2017
  • Chart 5-25: Prostate Cancer Assay Market, U.S., 2007 - 2017
  • Chart 5-26: Leading Competitors, Molecular Diagnostics Market, 2010

BLOOD DONOR SCREENING MARKET

  • Chart 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 - 2017
  • Chart 6-2: Total Blood Donor Screening Market by Segment, U.S., 2010
  • Chart 6-3: Total Blood Donor Screening Market by Segment, U.S., 2017
  • Chart 6-4: Total Blood Donor Screening Market, U.S., 2007 - 2017
  • Chart 6-5: Blood Donor Screening Analyzer Market, U.S., 2007 - 2017
  • Chart 6-6: Blood Donor Screening Assay Market, U.S., 2007 - 2017
  • Chart 6-7: Combined Assay Market, U.S., 2007 - 2017
  • Chart 6-8: WNV Assay Market, U.S., 2007 - 2017
  • Chart 6-9: HIV Assay Market, U.S., 2007 - 2017
  • Chart 6-10: HCV Assay Market, U.S., 2007 - 2017
  • Chart 6-11: HBV Assay Market, U.S., 2007 - 2017
  • Chart 6-12: Leading Competitors, Blood Donor Screening Reagent Market, U.S., 2007 - 2017

HEMOSTASIS MARKET

  • Chart 7-1: Total Hemostasis Market by Segment, U.S., 2007 - 2017
  • Chart 7-2: Total Hemostasis Market by Segment, U.S., 2010
  • Chart 7-3: Total Hemostasis Market by Segment, U.S., 2017
  • Chart 7-4: Total Hemostasis Market, U.S., 2007 - 2017
  • Chart 7-5: Hemostasis Analyzer Market, U.S., 2007 - 2017
  • Chart 7-6: Hemostasis Reagent Market, U.S., 2007 - 2017
  • Chart 7-7: Leading Competitors, Hemostasis Market, 2010

HEMATOLOGY MARKET

  • Chart 8-1: Total Hematology Market by Segment, U.S., 2007 - 2017
  • Chart 8-2: Total Hematology Market by Segment, U.S., 2010
  • Chart 8-3: Total Hematology Market by Segment, U.S., 2017
  • Chart 8-4: Total Hematology Market, U.S., 2007 - 2017
  • Chart 8-5: Total Hematology Analyzer Market, U.S., 2007 - 2017
  • Chart 8-6: High-End Analyzer Market, U.S., 2007 - 2017
  • Chart 8-7: Low-End Analyzer Market, U.S., 2007 - 2017
  • Chart 8-8: Hematology Reagent Market, U.S., 2007 - 2017
  • Chart 8-9: Leading Competitors, Hematology Market, 2010

POINT-OF-CARE TESTING MARKET

  • Chart 9-1: Total POC Testing Market by Segment, U.S., 2007 - 2017
  • Chart 9-2: Total POC Testing Market by Segment, U.S., 2010
  • Chart 9-3: Total POC Testing Market by Segment, U.S., 2017
  • Chart 9-4: Total POC Testing Market, U.S., 2007 - 2017
  • Chart 9-5: Total Clinical Chemistry Market, U.S., 2007 - 2017
  • Chart 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 - 2017
  • Chart 9-7: Clinical Chemistry Reagent Market, U.S., 2007 - 2017
  • Chart 9-8: Blood Gas Testing Market, U.S., 2007 - 2017
  • Chart 9-9: Total Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Chart 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Chart 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 - 2017
  • Chart 9-12: Total Blood Gas Reagent Market, U.S., 2007 - 2017
  • Chart 9-13: Single-Use Cartridge Market, U.S., 2007 - 2017
  • Chart 9-14: Multi-Use Cartridge Market, U.S., 2007 - 2017
  • Chart 9-15: Other Reagent Market, U.S., 2007 - 2017
  • Chart 9-16: POC Urinalysis Market, U.S., 2007 - 2017
  • Chart 9-17: Urinalysis Analyzer Market, U.S., 2007 - 2017
  • Chart 9-18: POC Urinalysis Test Strip Market, U.S., 2007 - 2017
  • Chart 9-19: POC Blood Glucose Testing Market, U.S., 2007 - 2017
  • Chart 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 - 2017
  • Chart 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 - 2017
  • Chart 9-22: Leading Competitors, Point-of-Care Testing Market, 2010

ABBREVIATIONS

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING

Back to Top